Thus, whereas LRIG1 suppresses ERBB2 expression and the proliferation of ERBB2-positive breast cancer cells, ERBB2 itself downregulates LRIG1 levels in breast cancer cells, thereby canceling the tumor-suppressive function of LRIG1 [13]. Here, ERBB2 is linked to breast cancer.